PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.27%
Revenue growth at 50-75% of MCHP's 10.82%. Martin Whitman would worry about competitiveness or product relevance.
7.27%
Gross profit growth under 50% of MCHP's 15.09%. Michael Burry would be concerned about a severe competitive disadvantage.
-368.46%
Negative EBIT growth while MCHP is at 140.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-368.46%
Negative operating income growth while MCHP is at 132.00%. Joel Greenblatt would press for urgent turnaround measures.
1.71%
Net income growth under 50% of MCHP's 87.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.11%
Share count expansion well above MCHP's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.11%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.19%
10Y revenue/share CAGR at 50-75% of MCHP's 51.09%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
31.19%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
31.19%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
317.31%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
317.31%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
317.31%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
13.09%
Below 50% of MCHP's 145.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
13.09%
5Y equity/share CAGR is in line with MCHP's 14.52%. Walter Schloss would see parallel mid-term profitability and retention policies.
13.09%
3Y equity/share CAGR at 50-75% of MCHP's 17.81%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-46.00%
Cut dividends over 10 years while MCHP stands at 180.63%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-46.00%
Negative 5Y dividend/share CAGR while MCHP stands at 175.02%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-46.00%
Negative near-term dividend growth while MCHP invests at 81.65%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.